UAE Business: G42 Healthcare to distribute Oxford Nanopore’s products – Gulf Digital News

UAE Business: G42 Healthcare to distribute Oxford Nanopore’s products – Gulf Digital News

Abu Dhabi’s G42 Healthcare has signed a distribution deal with Oxford Nanopore as a channel partner for its DNA/RNA sequencing products across Gulf Co-operation Council (GCC) countries, Jordan, Pakistan, Egypt and Iraq.

Oxford Nanopore’s sequencing devices include the MinION, GridION, PromethION, VolTRAX and Flongle. This agreement is aligned with G42 Healthcare’s vision to make UAE the regional hub of health and life sciences by offering technology for real-time, accurate, accessible, and scalable analysis of DNA and RNA.

The technology supports scientific analyses to further understand the biology of humans, bacteria, viruses, and environments as well as to understand diseases such as cancer.

Market disrupting features

With this channel partnership, G42 Healthcare aims to build on its current sequencing capabilities by offering Oxford Nanopore’s sequencing technology, which offers a range of market-disrupting features.

This includes the ability to sequence any length of DNA/RNA fragments, from short to ultra-long, thereby offering richer genomic insights; the ability to stream data in real-time for rapid insights; the ability to sequence native DNA/RNA strands to elucidate richer information including real-time methylation data. A range of analyses from whole genome assembly to targeted sequencing or metagenomic analysis can be performed.

In addition to distribution of the technology, G42 Healthcare has the option